About Medirin Pharmaceuticals
Medirin Pharmaceuticals is a Healthcare company founded in 2019. Manufacturing and distribution of pharmaceutical products in India. Its Indian entity Medirin Pharmaceuticals Private Limited reported revenue of ₹2.42 Cr. Medirin Pharmaceuticals offers products and services including Tablets and PCD Pharma Franchise. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medicines Production and Distribution.
Company details
Medirin Pharmaceuticals is identified as a pharmaceutical company based in India, with operations in Ahmedabad and Ambala. It is involved in the production of a wide range of products such as tablets, capsules, syrups, and injectables, which are prepared under GMP and WHO standards to ensure quality and efficacy. The company is recognized for providing PCD franchise opportunities, allowing distribution across various regions. Additionally, emphasis is placed on affordable herbal and ayurvedic medicines, supported by advanced RD and ethical practices, aiming to bridge gaps in healthcare services nationwide.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website medirin.com
- Social LinkedIn X Facebook
- Legal Name Medirin Pharmaceuticals Pvt. Ltd
- Date of Incorporation 27 May, 2019
- Jurisdiction Ambala Cantt, Haryana, India
- Indian entity revenue₹2.42 Cr
FY 2025 · +1778% YoY
- Indian entity net profit₹2.6 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹45.8 Lakh
FY 2025 · 19% margin
Associated legal entities of Medirin Pharmaceuticals
Medirin Pharmaceuticals operates through Medirin Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medirin Pharmaceuticals Private Limited CIN U24304HR2019PTC080556 | Active | 27 May 2019 | Ambala Cantt, Haryana | ₹2.4 Cr | 4 | View details |
Products & Services of Medirin Pharmaceuticals
Medirin Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and PCD Pharma Franchise.
Tablets for various therapeutic uses are manufactured and distributed by the company.
Franchise opportunities for pharmaceutical distribution are offered across India.
Board of directors of Medirin Pharmaceuticals Private Limited (Medirin Pharmaceuticals)
Medirin Pharmaceuticals Private Limited is the primary company behind Medirin Pharmaceuticals. The board of Medirin Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Raman Aggarwal, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raman Aggarwal DIN 08463458 | Director | 27 May 2019 | 7 yrs 5 mo | Medirin Pharmaceuticals Private Limited |
| Sanjeev Aggarwal DIN 08697240 | Director | 20 Feb 2020 | 6 yrs 8 mo | Medirin Pharmaceuticals Private Limited |
| Pankaj Aggarwal DIN 10491161 | Director | 02 Feb 2024 | 2 yrs 9 mo | Medirin Pharmaceuticals Private Limited |
| Tarun Dua DIN 08135411 | Director | 02 Feb 2024 | 2 yrs 9 mo | Medirin Pharmaceuticals Private Limited |
Financials of Medirin Pharmaceuticals
Figures of Medirin Pharmaceuticals Private Limited, the primary company behind Medirin Pharmaceuticals, for FY 2025. Revenue was ₹2.42 Cr (+1778% year on year). Net profit was ₹2.6 Lakh (1% margin). EBITDA was ₹45.8 Lakh (19% margin). Revenue has grown at a compounded annual rate of +19% over three years and +64% over five years.
- ₹2.42 CrRevenue · FY 2025 · +1778% YoY
- ₹2.6 LakhNet profit · 1% margin
- ₹45.8 LakhEBITDA · 19% margin
- ₹10 LakhPaid-up capital
- +19%Revenue CAGR, 3 years
- +64%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medirin Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Medirin Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medirin Pharmaceuticals
Medirin Pharmaceuticals was founded in 2019.
The primary company behind Medirin Pharmaceuticals, Medirin Pharmaceuticals Private Limited, reported revenue of ₹2.42 Cr for FY 2025, up 1778% year on year.
Medirin Pharmaceuticals is identified as a pharmaceutical company based in India, with operations in Ahmedabad and Ambala. It is involved in the production of a wide range of products such as tablets, capsules, syrups, and injectables, which are prepared under GMP and WHO standards to ensure quality and efficacy. The company is recognized for providing PCD franchise opportunities, allowing distribution across various regions. Additionally, emphasis is placed on affordable herbal and ayurvedic medicines, supported by advanced RD and ethical practices, aiming to bridge gaps in healthcare services nationwide.
Medirin Pharmaceuticals offers Tablets and PCD Pharma Franchise.
Medirin Pharmaceuticals operates through Medirin Pharmaceuticals Private Limited.
The legal entities of Medirin Pharmaceuticals currently have 4 directors, including Sanjeev Aggarwal, Raman Aggarwal, Pankaj Aggarwal and others.